首页 | 本学科首页   官方微博 | 高级检索  
检索        

DR—70^TM检测在消化系统肿瘤中的应用
引用本文:吴群,吴东方,谢文,余小萍,江桥.DR—70^TM检测在消化系统肿瘤中的应用[J].上海医学检验杂志,2001,16(6):346-347.
作者姓名:吴群  吴东方  谢文  余小萍  江桥
作者单位:武汉大学医学院微生物学及免疫学教研室 武汉430071 (吴群),武汉大学中南医院检验科 武汉430071 (吴东方,谢文,余小萍),武汉大学中南医院检验科 武汉430071(江桥)
摘    要:目的评价 DR- 70 TM在消化系肿瘤筛查中的价值。方法应用 EL ISA对 135例确诊为食道癌、胃癌、肠癌或肝癌的患者和 16 6例年龄相当的健康者进行了对照检测。结果以 5 .3mg/ L 为临界值 ,食道癌阳性率为92 .9%,胃癌阳性率为 92 .9%,肠癌阳性率为 83.3%,肝癌阳性率为 83.8%,合计总阳性率为 85 .8%;与健康对照组结果比较 ,P<0 .0 0 1,差异呈高度显著性。结论 DR- 70 TM可为消化系肿瘤临床提供参考依据

关 键 词:DR-70^TM  食道癌  胃癌  肠癌  肝癌  消化系肿瘤

Clinical application of the AMDL DR-70~(TM) immunoassay kit for the digestive system tumors.
WU Qun,et al..Clinical application of the AMDL DR-70~(TM) immunoassay kit for the digestive system tumors.[J].Shanghai Journal of Medical Laboratory Sciences,2001,16(6):346-347.
Authors:WU Qun  
Institution:WU Qun,et al. Department of Microbiology and Immunology,Wuhan University,Wuhan,430071,China
Abstract:Objective To evaluate the clinical value of DR 70 TM in digestive system tumors. Method A clinical study using DR 70 TM enzyme linked immunosorbent assay (ELISA) in 135 patients with digestive system tumors, including esophageal carcinoma, gastric cancer, cancers of colon and rectum, hepatic cancer and 166 healthy subjects. Results The positive rates of DR 70 TM were 92 85%,92 85%,83 33%,83 78% for esophageal carcinoma, gastric cancer, cancers of colon and rectum, hepatic cancer respectively. There was very significant difference between the patient group and control (P<0 001). Conclusion The DR 70 TM assay may be useful in clinical study of the digestive system cancers.
Keywords:DR  70    TM  Esophageal carcinoma  Gastric cancer  Colon and rectum cancer  Hepatic cancer
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号